Principles of clinically important drug interactions with carbamazepine. Part I.
Ketter
T A
TA
Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20892.
Post
R M
RM
Worthington
K
K
D000700:Analgesics / Q000494:pharmacology; D000777:Anesthetics / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000925:Anticoagulants / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D002220:Carbamazepine / Q000493:pharmacokinetics / Q000494:pharmacology*; D004347:Drug Interactions; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology
D000700:Analgesics; D000777:Anesthetics; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D002220:Carbamazepine